Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) (NCT04427384)
A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
🩺 Plain-English Summary (8th-Grade Level)
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Who can join: Review the eligibility criteria below.
Location: HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (54 Sites)
Showing the first 25 of 54 sites.
- HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona
- University of Arkansas Medical Center — Little Rock, Arkansas
- Eden Medical Center — Castro Valley, California
- UCSD Moores Cancer Center — La Jolla, California
- MemorialCare Health System — Laguna Hills, California
- Desert Regional Medical Center — Palm Springs, California
- California Pacific Medical Center, Sutter health — San Francisco, California
- Centura — Denver, Colorado
- Colorado Brain & Spine Institute: Swedish Campus — Englewood, Colorado
- BayCare Health — Clearwater, Florida
- Ascension St. Vincent's — Jacksonville, Florida
- Miami Cancer Institute, Baptist Health South Florida — Miami, Florida
- Advent Health Orlando — Orlando, Florida
- Orlando Health — Orlando, Florida
- Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital — Tampa, Florida
- Cleveland Clinic Florida- Weston — Weston, Florida
- Piedmont Healthcare — Atlanta, Georgia
- Winship Cancer Institute of Emory University — Atlanta, Georgia
- St. Alphonsus Regional Medical Center — Boise, Idaho
- Goodman Campbell Brain and Spine — Carmel, Indiana
- Indiana University, IU Health Methodist Hospital — Indianapolis, Indiana
- KUMC Dept of Neurosurgery — Kansas City, Kansas
- Univeristy of Louisville Health — Louisville, Kentucky
- Norton Cancer Institute — Louisville, Kentucky
- Willis-Knighton Medical Center — Shreveport, Louisiana
📞 Contact the Study Coordinator
Phone: (833) 662-0044
Email: mgarcia@gtmedtech.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Brain Tumor, Recurrent
- T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors — Houston, Texas
- Azoles Targeting Recurrent High Grade Gliomas — Toronto, Ontario
- Chronic CED of TPT for Recurrent Malignant Glioma — New York, New York
Explore by condition: All Brain Tumor, Recurrent clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.